• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment

NxStage Medical Inc

+ Add to Watchlist


12.2700 USD 0.0650 0.53%

As of 20:10:00 ET on 04/17/2014.

Snapshot for NxStage Medical Inc (NXTM)

Open: 12.3400 Day's Range: 12.1700 - 12.5300 Volume: 583,305
Previous Close: 12.3350 52wk Range: 8.7700 - 15.0000 1-Yr Rtn: +13.09%

Stock Chart for NXTM

No chart data available.
  • NXTM:US 12.2700
  • 1D
  • 1M
  • 1Y
Interactive NXTM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NXTM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2971
Est. EPS (USD) (12/2014) -0.4260
Est. PEG Ratio -
Market Cap (M USD) 751.19
Shares Outstanding (M) 61.22
30 Day Average Volume 670,795
Price/Book (mrq) 3.8213
Price/Sale (ttm) 2.8076
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NXTM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NXTM

NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company's primary product, the NxStage System One, is a small, portable hemodialysis system.

Jeffrey H Burbank "Jeff"CEO/FounderJoseph E Turk Jr "Joe"President
Matthew W TowseSenior VP/CFO/TreasurerWinifred L SwanSenior VP/General Counsel
More Company Profile & Key Executives for NXTM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil